Carregant...
Rational optimization of a human neutralizing antibody of SARS-CoV-2
SARS-CoV-2 has caused a worldwide epidemic of coronavirus disease 19 (COVID-19). Antibody drugs present an effective weapon for tens of millions of COVID-19 patients. Antibodies disrupting the interactions between the receptor-binding domain (RBD) of SARS-CoV-2 S protein and the angiotensin converti...
Guardat en:
| Publicat a: | Comput Biol Med |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Ltd.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8196228/ https://ncbi.nlm.nih.gov/pubmed/34147856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.compbiomed.2021.104550 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|